Literature DB >> 30040254

[Proton therapy centres opened; what next?]

Liesbeth J Boersma1,2, Marco van Vulpen3, Coen R N Rasch4, Johannes L A Langendijk5.   

Abstract

After a long period of societal discussion, proton therapy became available in the Netherlands in 2018. This therapy was introduced to the Netherlands in a unique manner. The proton centres have been given permission to treat a maximum of 2,200 patients per year, 4.4% of the total number of patients who receive radiotherapy. This group is selected using carefully chosen prediction models to estimate the chance of side effects. An individual patient will only be eligible for proton therapy when a clinically relevant difference in side effects can be expected in comparison with current photon therapy. What prediction models should be used and what differences in side effects justify the use of proton therapy are, and will be, laid down in national indication protocols. We expect that this will enable us to extend the good international reputation that the Netherlands has in the area of radiotherapy, and to cooperate in bringing proton therapy to a higher level internationally.

Entities:  

Mesh:

Year:  2018        PMID: 30040254

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  1 in total

Review 1.  Is there any benefit to particles over photon radiotherapy?

Authors:  Maria E Goossens; Marc Van den Bulcke; Thierry Gevaert; Lydie Meheus; Dirk Verellen; Jean-Marc Cosset; Guy Storme
Journal:  Ecancermedicalscience       Date:  2019-12-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.